Neurotherapeutics

The New Era of Multiple Sclerosis Therapeutics

Rohit Bakshi

Interferon Beta and Glatiramer Acetate Therapy

Corey A. McGraw, Fred D. Lublin

Natalizumab Therapy for Multiple Sclerosis

Jeremy Chataway, David H. Miller

Alemtuzumab Therapy for Multiple Sclerosis

Alasdair J. Coles

Humoral-Targeted Immunotherapies in Multiple Sclerosis

Sabeen Lulu, Emmanuelle Waubant

Remyelination Therapy for Multiple Sclerosis

Michael B. Keough, V. Wee Yong

Daclizumab Therapy for Multiple Sclerosis

Bibiana Bielekova

Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned

Harold L. Atkins, Mark S. Freedman

Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis

James M. Stankiewicz, Hadar Kolb, Arnon Karni, Howard L. Weiner

Disease-Modifying Therapy of Pediatric Multiple Sclerosis

Tanuja Chitnis

Treatment of Acute Relapses in Multiple Sclerosis

Regina Berkovich

Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy)

Andrew D. Goodman, Robert Thompson Stone

Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy

Thomas Tourdias, Vincent Dousset

Scriptaid, a Novel Histone Deacetylase Inhibitor, Protects Against Traumatic Brain Injury via Modulation of PTEN and AKT Pathway

Guohua Wang, Xiaoyan Jiang, Hongjian Pu, Wenting Zhang, Chengrui An, Xiaoming Hu, Anthony Kian-Fong Liou, Rehana K. Leak, Yanqin Gao, Jun Chen

Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson’s Disease

Kang-Woo Lee, Joo-Young Im, Jong-Min Woo, Hilary Grosso, Yoon-Seong Kim, Ana Clara Cristovao, Patricia K. Sonsalla, David S. Schuster, Marla M. Jalbut, Jose R. Fernandez, Michael Voronkov, Eunsung Junn, Steven P. Braithwaite, Jeffry B. Stock, M. Maral Mouradian

Deep Brain Stimulation of the Subthalamic Nucleus, but not Dopaminergic Medication, Improves Proactive Inhibitory Control of Movement Initiation in Parkinson's Disease

Emilie Favre, Bénédicte Ballanger, Stéphane Thobois, Emmanuel Broussolle, Philippe Boulinguez

Sixth Annual Huntington Disease Clinical Research Symposium